Clinicopathologic and Prognostic Implications of Programmed Death Ligand 1 Expression in Thymoma

The Annals of Thoracic Surgery
Shintaro YokoyamaKoichi Ohshima

Abstract

Programmed death ligand 1 (PD-L1) has been reported to be expressed in various malignancies and is considered to be a prognostic factor and an immunotherapeutic target. The aim of this study was to characterize PD-L1 expression in thymoma and determine statistical associations between this expression and clinical features. We reviewed formalin-fixed, paraffin-embedded tissue specimens from 82 thymoma cases accumulated at Kurume University, the majority of which achieved surgical complete resection. Expression of PD-L1 was evaluated by immunohistochemistry. Statistical associations between PD-L1 expression and clinicopathologic features were evaluated by using χ(2) test and Fisher's exact test. Disease-free survival and overall survival curves were established by the Kaplan-Meier method and compared using a log-rank test. Predictive factors for disease-free survival after complete resection were analyzed by using a Cox proportional hazards model in univariate and multivariate analysis. Overall, 44 thymoma cases (54%) revealed high PD-L1 expression. High PD-L1 expression was statistically associated with Masaoka stage III/IV disease (p = 0.043) and World Health Organization type B2 or B3 thymoma (p = 0.044). Disease-free survival...Continue Reading

References

Dec 16, 1998·The American Journal of Surgical Pathology·T T Kuo, J K Chan
Sep 14, 2010·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Rohit K JainSunil Badve
Oct 5, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Akira Masaoka
Oct 5, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jordan Schmitt, Patrick J Loehrer
Jun 22, 2011·The Thoracic and Cardiovascular Surgeon·M RiedH-S Hofmann
Aug 24, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Frank DetterbeckMeinoshin Okumura
Aug 24, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Nicolas GirardPatrick J Loehrer
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Jul 9, 2013·Biochemical and Biophysical Research Communications·Masaki NaganeOsamu Inanami
Feb 8, 2014·Current Treatment Options in Oncology·Anasuya Gunturi, David F McDermott
Apr 20, 2014·Journal of the American Academy of Dermatology·Junna ObaMasutaka Furue
May 2, 2014·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ariel PedoeemAdam Mor
Jun 14, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Najib SafieddineShaf Keshavjee
Sep 24, 2014·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Francesco GuerreraPier Luigi Filosso
Oct 18, 2014·International Immunology·George K Philips, Michael Atkins
Nov 18, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Sukhmani K PaddaHeather A Wakelee
Mar 24, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yuki KatsuyaKoji Tsuta

❮ Previous
Next ❯

Citations

Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Francesco FacchinettiMarcello Tiseo
Oct 18, 2016·Human Pathology·Alberto M Marchevsky, Ann E Walts
Mar 11, 2017·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Annikka WeissferdtCesar A Moran
Feb 19, 2017·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Marcello TiseoGiulio Rossi
Mar 5, 2018·International Journal of Hematology·Hiroaki Miyoshi, Koichi Ohshima
Mar 31, 2018·Hematological Oncology·Keisuke KawamotoKoichi Ohshima
Feb 14, 2018·Journal of Clinical Pathology·Emine Kilic BagirSemra Paydas
Nov 7, 2019·Journal of Clinical Medicine·Rumi HiguchiMasao Omata
Aug 11, 2017·Current Treatment Options in Oncology·Claire Merveilleux du VignauxNicolas Girard
Jul 6, 2018·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·David SusterSaul Suster
Apr 24, 2019·World Journal of Gastroenterology : WJG·Min-Wei YangDe-Jun Liu
May 12, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shintaro YokoyamaKoichi Ohshima
May 14, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shunta IshiharaMasayoshi Inoue
Aug 2, 2020·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shigeki UmemuraGiuseppe Giaccone
Aug 10, 2021·Frontiers in Oncology·Yang ZhangShisuo Du

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.